INmune Bio, Inc. (NASDAQ:INMB ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Christopher Barnum - Corporate Participant Daniel Carlson - Corporate Participant David J. Moss - CFO, Treasurer & Secretary Mark William Lowdell - Chief Scientific Officer & Chief Manufacturing Officer Raymond Joseph Tesi - Co-Founder, President, CEO, Chief Medical Officer & Chairman Conference Call Participants Boris Tolkachev - Freedom Broker, Research Division Denis Reznik - Raymond James Ltd.

SANTA CLARITA, Calif.--(BUSINESS WIRE)-- #30DaysFree--U-Haul announced that seven of its facilities in Southern California are available to provide 30 days of free self-storage and U-Box portable container use to evacuees and others who stand to be impacted by the Canyon Fire near Lake Piru. Thousands of residents across parts of Ventura and Los Angeles Counties are under evacuation orders due to the blaze, which had charred about 5,000 acres as of Friday morning. Castaic is among the communities near the fi.

Petróleo Brasileiro S.A. - Petrobras (NYSE:PBR ) Q2 2025 Earnings Conference Call August 8, 2025 10:15 AM ET Company Participants Eduardo de Nardi Ros - Corporate Participant Fernando Sabbi Melgarejo - Chief Financial Officer & Investor Relations Officer Magda Maria de Regina Chambriard - CEO & Non-Independent Director Renata Baruzzi - Chief Engineering, Technology, & Innovation Officer Sylvia Maria Couto dos Anjos - Chief Exploration & Production Officer Conference Call Participants Bruno Montanari - Morgan Stanley, Research Division Gabriel Coelho Barra - Citigroup Inc., Research Division Lilyanna Yang - HSBC Global Investment Research Luiz Felipe Carvalho - Banco BTG Pactual …

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH ) Q2 2025 Earnings Conference Call August 7, 2025 10:00 AM ET Company Participants Deborah Stewart - Senior VP & Principal Accounting Officer Jeffrey S. Shaner - CEO & Director Matthew Buckhalter - CFO & Principal Financial Officer Conference Call Participants Andrew Mok - Barclays Bank PLC, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Benjamin Michael Rossi - JPMorgan Chase & Co, Research Division Brian Gil Tanquilut - Jefferies LLC, Research Division David Samuel MacDonald - Truist Securities, Inc., Research Division Philip Chickering - Deutsche Bank AG, Research Division Raj Kumar - …

KVH Industries, Inc. (NASDAQ:KVHI ) Q2 2025 Earnings Conference Call August 7, 2025 9:00 AM ET Company Participants Anthony Pike - CFO & Chief Accounting Officer Brent C. Bruun - President, CEO & Director Conference Call Participants Christopher David Quilty - Quilty Space Inc., Research Division Operator Thank you for standing by.

BioLife Solutions, Inc. (NASDAQ:BLFS ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Roderick de Greef - CEO & Chairman Troy Wichterman - Chief Financial Officer Conference Call Participants Anna Snopkowski - KeyBanc Capital Markets Inc., Research Division Chad M. Wiatrowski - TD Cowen, Research Division Matthew Jay Stanton - Jefferies LLC, Research Division Yi Chen - H.C.

NEW YORK , Aug. 8, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) between June 22, 2023 and June 24, 2025, both dates inclusive (the "Class Period"), of the important August 25, 2025 lead plaintiff deadline. So What: If you purchased Sarepta Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

AVITA Medical, Inc. (NASDAQ:RCEL ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Ben Atkins - Corporate Participant David O'Toole - Chief Financial Officer James M. Corbett - CEO, President & Executive Director Conference Call Participants Joshua Thomas Jennings - TD Cowen, Research Division Ross Everett Osborn - Cantor Fitzgerald & Co., Research Division Operator Good day, and thank you for standing by.

MNST posts 23% EPS growth in Q2 as innovation, new product launches and global demand fuel strong performance.

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Leiv Lea - Chief Financial Officer Richard A. Miller - Co-Founder, President, CEO & Chairman of the Board Conference Call Participants Aydin Huseynov - Ladenburg Thalmann & Co. Inc., Research Division Jeffrey Michael Jones - Oppenheimer & Co. Inc., Research Division Zack Kubow - Real Chemistry, Inc. Operator Good afternoon, everyone.

Kodiak Gas Services, Inc. (NYSE:KGS ) Q2 2025 Earnings Conference Call August 7, 2025 10:00 AM ET Company Participants Graham Sones - Vice President of Investor Relations John B. Griggs - Executive VP & CFO Robert M.

PTC Therapeutics, Inc. (NASDAQ:PTCT ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Ellen Cavaleri - Corporate Participant Eric Pauwels - Chief Business Officer Jarwei Fang - Corporate Participant Matthew B. Klein - CEO & Director Pierre Gravier - Chief Financial Officer Conference Call Participants Dingding Shi - Jefferies LLC, Research Division Huidong Wang - Barclays Bank PLC, Research Division Jenny Leigh Gonzalez-Armenta - Leerink Partners LLC, Research Division John Peyton Bohnsack - TD Cowen, Research Division Joon So Lee - Truist Securities, Inc., Research Division Judah C.

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON SIMULATIONS PLUS, INC. (SLP), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On July 14, 2025, after market hours, Simulations Pl.

South Bow Corporation (NYSE:SOBO ) Q2 2025 Earnings Conference Call August 7, 2025 10:00 AM ET Company Participants Bevin Mark Wirzba - President, CEO & Director Martha Wilmot - Corporate Participant P. Van R. Dafoe - Senior VP & CFO Richard J.

Grupo Cibest S.A. (NYSE:CIB ) Q2 2025 Earnings Conference Call August 8, 2025 9:00 AM ET Company Participants Juan Carlos Mora Uribe - President & CEO Laura Clavijo - Corporate Participant Chief Economist - Corporate Participant Mauricio Botero Wolff - VP of Strategy & Finance and CFO Conference Call Participants Andres Soto - Santander Investment Securities Inc., Research Division Brian Flores - Citigroup Inc., Research Division Carlos Gomez-Lopez - HSBC Global Investment Research Ernesto María Gabilondo Márquez - BofA Securities, Research Division Lindsey Marie Shema - Goldman Sachs Group, Inc., Research Division Yuri Rocha Fernandes - JPMorgan Chase & Co, …

CorMedix, Inc. (NASDAQ:CRMD ) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Joseph Todisco - CEO & Director Matthew T. David - Executive VP & CFO Conference Call Participants Anish Nikhanj - RBC Capital Markets, Research Division Brandon Richard Folkes - H.C.

Sun Life Financial Inc. (NYSE:SLF ) Q2 2025 Earnings Conference Call August 8, 2025 10:00 AM ET Company Participants Daniel Richard Fishbein - President of Sun Life U.S. Kevin David Strain - President, CEO & Director Manjit Singh - President of Sun Life Asia Natalie Brady - Senior Vice President of Capital Management & Investor Relations Stephen Clarkson Peacher - President of SLC Management Ted Maloney - Corporate Participant Timothy Deacon - Executive VP & CFO Conference Call Participants Darko Mihelic - RBC Capital Markets, Research Division Doug Young - Desjardins Securities Inc., Research Division Gabriel Dechaine - National Bank …

Crane NXT, Co. (NYSE:CXT ) Q2 2025 Earnings Conference Call August 7, 2025 10:00 AM ET Company Participants Aaron W. Saak - President, CEO & Director Christina Cristiano - Senior VP & CFO Matt Roache - Vice President of Investor Relations Conference Call Participants Damian Mark Karas - UBS Investment Bank, Research Division Isaac Arthur Sellhausen - Oppenheimer & Co. Inc., Research Division Matt J.

Investor sentiment has shifted away from small/mid-cap stocks, but I see Atlassian's recent selloff as an overreaction and a buying opportunity. Atlassian remains a market leader with strong AI-driven growth potential, high gross margins, and a unique, efficient sales model. The company has successfully transitioned to a recurring subscription model, stabilizing revenue and maintaining Rule of 40 metrics with solid growth and profitability.

Chime CEO Chris Britt says the company's user growth is more seasonal than investors realize. Britt talks about the fintech company's first earnings report as a public company and responds to the share price drop in a conversation with Caroline Hyde on “Bloomberg Tech.